Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.2K Buy
12,498
+1,009
+9% +$3.15K ﹤0.01% 452
2026
Q1
$33.5K Buy
+11,489
New +$32.8K ﹤0.01% 463

Other funds holding ABEV

Equitable Trust's ABEV Position: Q2 2026 in Review

Equitable Trust increased its Ambev (ABEV) stake by 8.8% in Q2 2026, buying an estimated $3.15K and bringing the position to 12,498 shares worth $39.2K. The position accounts for ﹤0.01% of the portfolio, ranked #452.

Equitable Trust first reported a position in ABEV in Q1 2026 and has held it in 2 quarters since. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Equitable Trust held 12,498 shares of Ambev worth $39.2K as of Q2 2026.
  • Equitable Trust bought 1,009 Ambev shares in Q2 2026, an estimated $3.15K.
  • Ambev made up ﹤0.01% of Equitable Trust's portfolio in Q2 2026, its #452 holding.
  • Equitable Trust first reported a position in Ambev in Q1 2026 and has held it in 2 quarters since.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Equitable Trust's 13F filing for Q2 2026, filed 23 Jul 2026.